TP53 and hepatocellular carcinoma: Kong et al. used redox-responsive particles (PDSA added) to deliver p53 mRNA in models of hepatocellular carcinomas (HCCs) and non-small-cell lung cancers (NSCLCs) and showed an effect on tumor growth inhibition.